The side effects of targeted drugs are poorly documented, and their impact on patients frequently seriously underestimated and undertreated. Efforts to address these issues could improve survival as well as quality of life.
by Peter McIntyre
http://www.cancerworld.org/Articles/Issues/65/March-April-2015/Patient-V...
